US · guidance
CMS Pub. 100-18, ch. 6, § 10.14.3
Other Vaccine Administration Considerations
Part D sponsors may implement drug utilization management tools to determine if a vaccine is
necessary; however, in the absence of any information showing previous immunization (i.e.,
claims data), the Part D sponsor should make payment available for a vaccine and its
administration consistent with Advisory Committee on Immunization Practices (ACIP)
recommendations.
History
(Rev. 2, Issued: 07-18-08; Effective/Implementation Date: 07-18-08)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-09-17
- Edition
- iom-2026-09-17
- Content hash
5ae5ebb0535bff8d2cec99cf9e50c36b38a4da8cdfd36b448752818bcac4ca24
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.